Associate Director, Global Associate Compound Market Access Leader - Neuroscience

Company: Disability Solutions
Location: Raritan
Posted on: April 20, 2024

Job Description:

Janssen Global Commercial Strategy Neuroscience Therapeutic Area, a group within Janssen Global Services and a member of Johnson & Johnson's family of companies, is recruiting for an Associate Director, Global Associate Compound Market Access Leader (Assoc. CMAL). This position will be based in Raritan, NJ. At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at . The Associate Director, reporting to the Compound Market Access Leader (CMAL), Neuroscience TA, has a key leadership role in developing and driving the market access strategy for the respective product/indication, aligned with the global brand strategy. In doing so, the Associate CMAL will shape key strategic decisions such as clinical development and integrated evidence generation. The Associate CMAL takes a lead in development of brand value propositions and collaborates through the Compound and Extended Market Access Teams (CMAT / EMAT) to deliver timely, optimal reimbursement in a highly challenging environment across diverse regions with complex and differing needs. The Associate CMAL must understand the needs of markets and develop appropriate solutions. Key Responsibilities: --- Support the Compound Market Access Leader (CMAL) for strategic planning and implementation of the payer value generation and access strategies for the product / indication in scope. --- Drive the design and management of health outcomes studies for the indication including systematic literature reviews, meta-analyses, real world evidence studies, and user-friendly cost effectiveness and budget impact models that can be adapted for coordinated delivery to key decision makers. --- Interact with Regional Market Access/Health Economics / Outcomes Research and Medical Affairs teams to coordinate and develop real world evidence generation in support of their access programs. --- Provide leadership to the indication specific clinical working group (CWG) in terms of market access data needs related to the clinical development plan. --- Act as part of cross-functional Global Indication Team with Global Commercial & Medical Affairs and ensure appropriate evidence is generated to develop robust differentiable value proposition for the indication at launch and during life cycle management. --- Foster collaboration, alignment, and seamless working across R&D and GCSO functions, including the Compound Development Team (CDT), Commercial, Medical Affairs, and Global Market Access COE to ensure optimal launch readiness for the brand. --- Take indication specific budgetary responsibility, ensuring that spending is managed effectively throughout the year and to plan. --- Keep up to date with scientific developments, bringing the latest techniques and analyses to build the strongest possible value proposition. --- Understand the patient perspective of the disease and recommend strategies that can support the patient voice in key payer negotiations.

Keywords: Disability Solutions, Perth Amboy , Associate Director, Global Associate Compound Market Access Leader - Neuroscience, Executive , Raritan, New Jersey